<DOC>
	<DOCNO>NCT00328536</DOCNO>
	<brief_summary>The purpose study determine whether 6-week treatment 4 g Omacor/day improve baseline postprandial endothelial function ( high-fat meal ) patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Omacor Treatment Vascular Dysfunction Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Patients type 2 diabetes mellitus ( T2DM ) 2 5-fold increase cardiovascular mortality compare non-diabetics . Endothelial dysfunction ( ED ) early messenger atherosclerosis present state show high cardiovascular ( CV ) risk , active passive smoking , dyslipidemia , arterial hypertension , obesity , hyperhomocysteinemia , coronary artery disease , congestive heart failure type 1 type 2 diabetes mellitus . Endothelial function variable large day-to-day variation show great excursion even within one day . Several factor might play role hormonal status , physical activity , sleep quality , important seem postprandial state . Postprandial ED demonstrate patient CV disease diabetes , even healthy subject . A large body evidence accumulate show distinctive cumulative effect hyperglycemia hypertriglyceridemia postprandial ED . Since postprandial dysmetabolism link CVD , ED propose mechanism connect . Considering postprandial state cover daytime , intervention target reduction postprandial ED might play decisive role atherosclerosis prevention . For treatment postprandial ED several therapeutical approach suggest folic acid , tetrahydrobiopterin , vitamins C E statin . Some property omega-3 fatty acid suggest impairment postprandial endothelial dysfunction could prevent treatment OmacorÂ® purpose study demonstrate six-week therapy Omacor prevent endothelial dysfunction fast state follow high-fat meal . Several control clinical study conduct person TM2DM myocardial infarction show consumption omega-3 long chain polyunsaturated fatty acid ( n-3 PUFA ) several beneficial effect : lower risk primary cardiac arrest , reduces triglyceride level , increase high-density lipoprotein level , reduces platelet aggregability , act anti-inflammatory immune-modulating , lower blood pressure improve endothelial function . Consumption n-3 fatty acid show positively influence platelet , fibrinolytic vascular function hypertensive type 2 diabetic patient . Mediterranean- style diet restore marker endothelial dysfunction inflammation person metabolic syndrome improves endothelial function hypercholesterolemic men . Since Omacor contain high-dose purified n-3 fatty acid eicosapentaenoic docosahexaenoic acid ( EPA DHA ) , first hypothesis 6-week therapy 4g/d Omacor improves fast endothelial function person T2DM . In patient T2DM , three-week diet high amount polyunsaturated fatty acid compare diet high amount monounsaturated fatty acid , produce significantly low increase postprandial lipemia oral fat load . Since postprandial lipemia induces transient endothelial dysfunction , second hypothesis treatment Omacor prevent postprandial impairment endothelial function high fat meal .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Type 2 diabetes mellitus History myocardial infarction , stroke Severe diabetes complication Severe hypo hypertension Chronic alcohol abuse Renal failure</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>flow-mediated vasodilatation</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>postprandial state</keyword>
</DOC>